 |
Advanced BCCs can develop in difficult-to-treat areas such as the periorbital region, and treatment may result in sequelae such as deformity and loss of vision.1-4 When the location of the advanced BCC presents treatment challenges… WHAT'S NEXT FOR THESE PATIENTS? |
|||||
 |
||||||
|
 |
|
||
|
|
Genentech is investigating the molecular basis of skin cancers such as advanced BCC. Register now for more information. References: 1. Leibovitch I, McNab A, Sullivan T, Davis G, Selva D. Orbital invasion by periocular basal cell carcinoma. Ophthalmology. 2005;112:717-723. 2. Tildsley J, Diaper C, Herd R. Mohs surgery vs primary excision for eyelid BCCs. Orbit. 2010;29:140-145. 3. Randle HW. Basal cell carcinoma: identification and treatment of the high-risk patient. Dermatol Surg. 1996;22:255-261. 4. García Martín E, Fernández Tirado FJ. Periocular basal cell carcinoma treatment tendencies. Arch Soc Esp Oftalmol. 2010;85:261-262. Privacy Policy | Terms and Conditions | Contact Genentech® This e-mail is intended for U.S. healthcare professionals only. Genentech USA, Inc. 1 DNA Way South San Francisco, CA 94080-4990 © 2011 Genentech USA, Inc. All rights reserved. To unsubscribe from the Genentech mailing list, please click here. HED0000676800 |
|
|
 |
||||